As a continuous variable, TREM1 expression was associated with poorer DMFS, univariately (P = 1.9x10-13), as well as in the multivariable model (P = 3.2x10-05), where it remained significant in the presence of molecular subtype, immune subclass, histologic grade, tumor size, lymph node status, ER status, patient age, and treatment status. Here, ESR1 is linked to neoplasm.